In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.